Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Kim

Showing results (681-690 of 691) with videos related to

Pageof 70
Sort By:
Science (New York, N.Y.)|December 1, 2018
Isostructural metal-insulator transition in VO<sub>2</sub>D Lee, B Chung, Y Shi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 26, 2006
Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean populationJ-Y Hwang, J-Y Lee, M-H Park, et al.
Nature Communications|September 17, 2020
Controlling spin current polarization through non-collinear antiferromagnetismT Nan, C X Quintela, J Irwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerP Harter, F Trillsch, A Okamoto, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 13, 2012
Clinical characteristics of patients with tuberculosis-destroyed lungC K Rhee, K H Yoo, J H Lee, et al.
ESMO Open|March 11, 2026
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) studyS Y Ryu, B H Nam, M H Kim, et al.
ESMO Open|July 8, 2026
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapiesJ W Kim, Y H Park, S Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Exploring global barriers to optimal ovarian cancer care: thematic analysisSelina Sfeir, Lucy Allen, Marc Daniël Algera, et al.
ESMO Open|July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisS Camera, A Vogel, M Rimini, et al.
Pageof 70

Showing results (681-690 of 691) with videos related to

Sort By:
Pageof 70
Science (New York, N.Y.)|December 1, 2018
Isostructural metal-insulator transition in VO<sub>2</sub>D Lee, B Chung, Y Shi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 26, 2006
Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean populationJ-Y Hwang, J-Y Lee, M-H Park, et al.
Nature Communications|September 17, 2020
Controlling spin current polarization through non-collinear antiferromagnetismT Nan, C X Quintela, J Irwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2025
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancerP Harter, F Trillsch, A Okamoto, et al.
Oncogene|July 25, 2012
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomasP Wang, Q Dong, C Zhang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 13, 2012
Clinical characteristics of patients with tuberculosis-destroyed lungC K Rhee, K H Yoo, J H Lee, et al.
ESMO Open|March 11, 2026
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) studyS Y Ryu, B H Nam, M H Kim, et al.
ESMO Open|July 8, 2026
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapiesJ W Kim, Y H Park, S Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Exploring global barriers to optimal ovarian cancer care: thematic analysisSelina Sfeir, Lucy Allen, Marc Daniël Algera, et al.
ESMO Open|July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisS Camera, A Vogel, M Rimini, et al.
Pageof 70